+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

From
Kidney Cancer Diagnostics and Therapeutics Market Report 2025 - Product Thumbnail Image

Kidney Cancer Diagnostics and Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Gynecology Drugs - Global Strategic Business Report - Product Thumbnail Image

Gynecology Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 386 Pages
  • Global
From
Regenerative Medicine Market 2025-2029 - Product Thumbnail Image

Regenerative Medicine Market 2025-2029

  • Report
  • March 2025
  • 225 Pages
  • Global
From
From
Anti-Infectives - Global Strategic Business Report - Product Thumbnail Image

Anti-Infectives - Global Strategic Business Report

  • Report
  • November 2025
  • 116 Pages
  • Global
From
Caspofungin - Global Strategic Business Report - Product Thumbnail Image

Caspofungin - Global Strategic Business Report

  • Report
  • November 2025
  • 279 Pages
  • Global
From
Cryptococcosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Cryptococcosis Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 473 Pages
  • Global
From
Typhoid Treatment - Global Strategic Business Report - Product Thumbnail Image

Typhoid Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 366 Pages
  • Global
From
Oropharyngeal Candidiasis - Global Strategic Business Report - Product Thumbnail Image

Oropharyngeal Candidiasis - Global Strategic Business Report

  • Report
  • November 2025
  • 462 Pages
  • Global
From
Oral Antivirals - Global Strategic Business Report - Product Thumbnail Image

Oral Antivirals - Global Strategic Business Report

  • Report
  • November 2025
  • 380 Pages
  • Global
From
From
Encephalitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Encephalitis Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 478 Pages
  • Global
From
From
Antifungal Drugs - Global Strategic Business Report - Product Thumbnail Image

Antifungal Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 179 Pages
  • Global
From
Clostridium Difficile Treatment - Global Strategic Business Report - Product Thumbnail Image

Clostridium Difficile Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 192 Pages
  • Global
From
MRSA Drugs - Global Strategic Business Report - Product Thumbnail Image

MRSA Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 183 Pages
  • Global
From
Loading Indicator